[HTML][HTML] New and emerging treatment options for irritable bowel syndrome

BE Lacy, WD Chey, AJ Lembo - Gastroenterology & hepatology, 2015 - ncbi.nlm.nih.gov
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder associated with
abdominal pain, diarrhea, constipation, or a mix of symptoms. The pathophysiology of IBS is …

[HTML][HTML] Diet, fibers, and probiotics for irritable bowel syndrome

AN Galica, R Galica, DL Dumitrașcu - Journal of medicine and life, 2022 - ncbi.nlm.nih.gov
Many aspects make irritable bowel syndrome (IBS) challenging for both patients and
physicians. The unclear pathogenesis with many pathways to be explored, bothering …

Novel pharmacological therapies for irritable bowel syndrome

M Corsetti, P Whorwell - Expert Review of Gastroenterology & …, 2016 - Taylor & Francis
Irritable bowel syndrome (IBS) is a prevalent functional gastrointestinal disorder, which
represents a major cost to healthcare services. Current pharmacological treatment includes …

Current gut-directed therapies for irritable bowel syndrome

HY Chang, EC Kelly, AJ Lembo - Current Treatment Options in …, 2006 - Springer
Opinion statement Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder
that can present with a wide array of symptoms that make treatment difficult. Current …

Management of irritable bowel syndrome with diarrhea: a review of nonpharmacological and pharmacological interventions

DJ Cangemi, BE Lacy - Therapeutic advances in …, 2019 - journals.sagepub.com
Irritable bowel syndrome (IBS) is a common gastrointestinal (GI) condition involving
numerous potential causative factors (eg alterations in gut microbiota, motility, brain–gut …

The treatment of irritable bowel syndrome

BE Lacy, K Weiser, R De Lee - Therapeutic Advances in …, 2009 - journals.sagepub.com
Irritable bowel syndrome (IBS) is a highly prevalent functional bowel disorder routinely
encountered by healthcare providers. Although not life-threatening, this chronic disorder …

Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents

RH Thomas, DR Luthin - Pharmacotherapy: The Journal of …, 2015 - Wiley Online Library
Irritable bowel syndrome with constipation (IBS‐C) and chronic idiopathic constipation (CIC)
are two common functional gastrointestinal disorders that impair quality of life and pose a …

Recent advances in diagnosis and management of irritable bowel syndrome

K Van den Houte, E Colomier, J Schol… - Current Opinion in …, 2020 - journals.lww.com
Irritable bowel syndrome has evolved into a disorder of interaction between dietary factors
and gut microbiota, with impact on bowel symptoms as well as extra-intestinal, central …

Update on pharmacotherapy for irritable bowel syndrome

A Munjal, B Dedania, B Cash - Current Gastroenterology Reports, 2019 - Springer
Abstract Purpose of Review Irritable bowel syndrome (IBS) is a functional GI disorder that
affects a large percentage of the population and presents a significant socio-economic …

New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists

AE Foxx-Orenstein - Therapeutic Advances in …, 2016 - journals.sagepub.com
Irritable bowel syndrome is a functional bowel disorder with gastrointestinal symptoms (eg
abdominal pain, straining, urgency, incomplete evacuation, nausea, and bloating) that occur …